Precision Medicine Delivered with Empathy


The Emory Empathetic AI for Health Institute (AI Health) harnesses the power of machine learning and big data to transform how healthcare systems prevent, diagnose, treat, and cure diseases. The three-pronged mission of the institute is to innovate, deploy, and scale up cost-effective and proportionally accessible artificial intelligence (AI) tools into healthcare solutions for patients at Emory Healthcare and, ultimately, across the globe. Launched in fall 2023, the Empathetic AI Health Institute is part of AI.Humanity, a university-wide initiative dedicated to shaping the artificial intelligence revolution to better human health, generate economic value, and promote ethical practices.

Inroads Against Common Diseases


Faculty associated with AI.Health are working to improve the detection, diagnosis, prognosis, and prediction of treatment response for more than two dozen conditions including lung cancer, prostate cancer, breast cancer, heart disease, kidney disease, diabetes, and diseases of the eye. The institute is led by Anant Madabhushi, a global leader, innovator, and entrepreneur in developing and deploying AI to improve outcomes for individuals with cancer and other diseases. Madabhushi’s team has collectively received more than $100M in research funding.

Learn more about our research
Microscopic slide of cancer cells

Success To Date

The Madabhushi team has already achieved significant translational success including:

200+

awarded or pending patents, averaging one per month

3

spin-off companies

40

technologies licensed

$100M+

funding raised by cofounded companies

510K

FDA approval for AI cardiac disease product

4+

Public-private partnerships with leading pharmaceutical companies

"Eye Connect" AI for Ophthalmology Mini-Symposium


April 25, 2025

“EYE CONNECT” AI for Ophthalmology Mini-Symposium

April 25, 2025

1:00 pm-5:00 pm

HSRB I Auditorium.

1760 Haygood Dr NE, Atlanta, GA 30322

Register